Top Markets
Coin of the day
Nutra Pharma Corp. Nutra Pharma Corp.

Nutra Pharma Corp.

NPHC
Rang in Aktien #38964
Nutra Pharma Corp. (NPHC) operates as a biopharmaceutical firm specializing in... Nutra Pharma Corp. (NPHC) operates as a biopharmaceutical firm specializing in obtaining, licensing, and bringing to market a variety of pharmaceutical products, cutting-edge technologies, and both homeopathic and ethical medications. The company primarily targets the U.S. market, focusing its efforts on managing conditions such as pain, neurological ailments, cancer, autoimmune diseases, and infectious diseases. Its current commercial offerings include: Nyloxin and Nyloxin Extra Strength: These products are distributed as an oral spray for alleviating lower back pain, migraines, neck and shoulder discomfort, cramps, and neuropathic pain, and as a topical gel to relieve joint pain, arthritis, and repetitive stress injuries. Pet Pain-Away: An over-the-counter (OTC) homeopathic, non-narcotic, and non-addictive solution for chronic pain in household pets. Luxury Feet: An OTC pain reliever and anti-inflammatory designed to ease foot pain or discomfort specifically caused by high heels and stilettos. Nyloxin Military Strength: A specialized formulation for pain relief aimed at the United States Military and Veteran's Administration. Equine Pain-Away: An OTC topical pain management product for horses. Beyond its existing portfolio, Nutra Pharma Corp. is also advancing several pipeline candidates: RPI-78M: In development to treat neurological conditions such as multiple sclerosis, adrenomyeloneuropathy, and amyotrophic lateral sclerosis, alongside autoimmune diseases like rheumatoid arthritis and myasthenia gravis. RPI-MN: Under investigation for viral diseases, including human immunodeficiency virus (HIV/AIDS) and herpes, as well as for general antiviral applications. RPI-78: Being developed for applications in pain and arthritis. RPI-70: Also in development for pain relief. Founded in 2000, the company is headquartered in Plantation, Florida.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2026-08-13
Marktkapitalisierung
$715.97K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-50.00%
Land
US
Handel Nutra Pharma Corp. (NPHC)

Kategorie

Preis NPHC mit Marktkapitalisierung von B
Nutra Pharma Corp. Nutra Pharma Corp.
NPHC
$0.0001
Marktkapitalisierung von Nutra Pharma Corp.(NPHC)
Marktkapitalisierung: $715.97K
Mit Stand August 2026 hat Nutra Pharma Corp. eine Marktkapitalisierung von $715.97K. Das macht Nutra Pharma Corp. laut unseren Daten zum 38964th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Nutra Pharma Corp. von 2001 bis 2026
NPHC im Vergleich zu den Top 5 der beliebtesten stocks
Preis für NPHC Vermögenswert B Marktkapitalisierung von B Ergebnisse
Nutra Pharma Corp. Nutra Pharma Corp.
$763.93 $715.97K
$5.470T +763,930,631.75%
Nutra Pharma Corp. Nutra Pharma Corp.
$623.92 $715.97K
$4.467T +623,916,053.72%
Nutra Pharma Corp. Nutra Pharma Corp.
$582.99 $715.97K
$4.174T +582,985,891.00%
Nutra Pharma Corp. Nutra Pharma Corp.
$516.79 $715.97K
$3.700T +516,789,961.85%
Nutra Pharma Corp. Nutra Pharma Corp.
$398.67 $715.97K
$2.854T +398,666,148.52%